
Rabmel-LS Capsule SR
Manufacturer
Meltic Healthcare Pvt Ltd
Salt Composition
Levosulpiride (75mg) + Rabeprazole (20mg)
Key Information
Short Description
Rabmel-LS Capsule SR is a prescription medicine used to treat gastroesophageal reflux disease (acid reflux), intestinal ulcers, and irritable bowel syndrome.
Dosage Form
Capsule SR
Introduction
Rabmel-LS Capsule SR is taken with or without food in a dose and duration as advised by the doctor. The dose you are given will depend on your condition and how you respond to the medicine. You should keep taking this medicine for as long as your doctor recommends. If you stop treatment too early your symptoms may come back and your condition may worsen. Let your healthcare team know about all other medications you are taking as some may affect or be affected by this medicine.
Directions for Use
Take this medicine in the dose and duration as advised by your doctor. Swallow it as a whole. Do not chew, crush or break it. Rabmel-LS Capsule SR is to be taken empty stomach.
Safety Information
Side Effects
The most common side effects are nausea, stomach pain, diarrhea, flatulence, constipation, headache, weakness, and flu-like symptoms.
Alcohol Warning
It is unsafe to consume alcohol with Rabmel-LS Capsule SR.
Breastfeeding Warning
Information regarding the use of Rabmel-LS Capsule SR during breastfeeding is not available. Please consult your doctor.
Pregnancy Warning
Rabmel-LS Capsule SR may be unsafe to use during pregnancy. Although there are limited studies in humans, animal studies have shown harmful effects on the developing baby. Your doctor will weigh the benefits and any potential risks before prescribing it to you. Please consult your doctor.
How it works
Rabmel-LS Capsule SR is a combination of two medicines: Levosulpiride and Rabeprazole.
Quick Tips
Do not consume alcohol while taking Rabmel-LS Capsule SR as it can increase the risk of stomach damage. Long-term use may cause weak or broken bones. Take adequate intake of dietary calcium and vitamin D or their supplements. Do not take Rabmel-LS Capsule SR for longer than prescribed.
Related Medicines

Ansuper-Plus Capsule SR

Rablet L Capsules

Veloz L Capsule

Acera-L Capsule SR

Colosafe-L Capsule SR

Razo-L Capsule

Rabemac LS Capsule

Rabonik Plus Capsule SR

Rabib-LS Capsule SR

Rdsto L 75mg/20mg Capsule SR
Frequently asked questions
Which is the best time to take Rabmel-LS Capsule SR?
Take Rabmel-LS Capsule SR exactly as directed by your doctor. It is recommended to take one capsule daily on an empty stomach.
What are the contraindications associated with the use of Rabmel-LS Capsule SR?
Use of Rabmel-LS Capsule SR should be avoided in patients with known allergy to any of the components or excipients of this medication. Consult your physician if you have any concerns.
Can the use of Rabmel-LS Capsule SR cause dizziness?
Yes, some patients may experience dizziness (feeling faint, weak, unsteady, or lightheaded) while taking Rabmel-LS Capsule SR. If you feel dizzy or lightheaded, it's recommended to rest and resume only when you feel better.
Does the use of Rabmel-LS Capsule SR lead to increased risk of fractures?
Several studies in adults have suggested that treatment with Rabmel-LS Capsule SR might be associated with an increased risk of osteoporosis-related fractures of the hip, wrist, or spine. This risk was higher in patients taking high doses and long-term therapy (for a year or longer). High dose refers to multiple daily doses and prolonged use.
Can I drive while taking Rabmel-LS Capsule SR?
Rabmel-LS Capsule SR may cause drowsiness, dizziness, or impaired vision. Do not drive or operate machinery until you understand how this medication affects your body and its abilities.
What are the instructions for the storage and disposal of Rabmel-LS Capsule SR?
Store Rabmel-LS Capsule SR in its original packaging, tightly closed. Refer to the instruction booklet or label on the pack for detailed storage recommendations and do not consume any unused medicine. Ensure it is kept out of reach of children, pets, and unauthorized individuals.